MTOR and hepatocellular carcinoma: A recent study revealed that upregulation of circRNA-100338 was associated with poor prognosis in patients with hepatitis B-related HCC by activating the mammalian target of rapamycin signaling pathway in HCC via the circRNA-100338/miR-141-3p/RHEB axis29.